ArticleOncoimmunology

Low-dose cyclophosphamide depletes circulating naïve and activated regulatory T cells in malignant pleural mesothelioma patients synergistically treated with dendritic cell-based immunotherapy.

Lisanne Noordam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.